Utama › Leukemia Limfoblastik Akut › California › Baldwin Park
Kajian klinikal Leukemia Limfoblastik Akut di Baldwin Park, CA
21 kajian untuk Leukemia Limfoblastik Akut sedang mencari peserta di lokasi dalam dan sekitar Baldwin Park (dalam lingkungan kira-kira 30 batu). Buka kajian untuk melihat siapa yang layak menyertai dan cara menghubungi pasukan kajian.
Teks kajian rasmi (Bahasa Inggeris)
Mengambil peserta untuk kajian di sini? Paparkan di bahagian atas halaman ini — $99 selama 30 hari →
A Phase 1 Study of Orca-Q in Recipients Undergoing Allogeneic Transplantation for Hematologic Malignancies
Mengambil pesertaFasa 1
- City of Hope, Duarte · 4 mi jauh
A Phase 2 Study of WU-CART-007, an Anti-CD7 Allogeneic CAR-T Cell Therapy in T-Cell Acute Lymphoblastic Leukemia and Lymphoblastic Lymphoma (T-RRex)
Mengambil pesertaFasa 2
- City of Hope, Duarte · 4 mi jauh
A Study of Obecabtagene Autoleucel in People With B-cell Acute Lymphoblastic Leukemia
Mengambil pesertaFasa 2
- City of Hope Cancer Center (Data collection AND Specimen Analysis), Duarte · 4 mi jauh
225Ac-DOTA-Anti-CD38 Daratumumab Monoclonal Antibody With Fludarabine, Melphalan and Total Marrow and Lymphoid Irradiation as Conditioning Treatment for Donor Stem Cell Transplant in Patients With High-Risk Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia and Myelodysplastic Syndrome
Mengambil pesertaFasa 1
- City of Hope Medical Center, Duarte · 4 mi jauh
A Vaccine (CMV-MVA Triplex Vaccine) for the Enhancement of CMV-Specific Immunity and the Prevention of CMV Viremia in Patients Undergoing Haploidentical Hematopoietic Stem Cell Transplant
Mengambil pesertaFasa 1Sukarelawan sihat dialu-alukan
- City of Hope Medical Center, Duarte · 4 mi jauh
Study of AZD4512 Monotherapy or in Combination With Anticancer Agents in Participants With Acute Lymphoblastic Leukemia
Mengambil pesertaFasa 1/2
- Research Site, Duarte · 4 mi jauh
A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)
Mengambil pesertaKajian pemerhatian
- City of Hope, Duarte · 4 mi jauh
Vedolizumab Plus Post-transplant Cyclophosphamide and Short Course Tacrolimus for the Prevention of Graft Versus Host Disease in Patients Undergoing Allogeneic Hematopoietic Cell Transplantation After Reduced Intensity Conditioning
Mengambil pesertaFasa 2
- City of Hope Medical Center, Duarte · 4 mi jauh
A Study of Revumenib and Mezigdomide in People With Leukemia
Mengambil pesertaFasa 1/2
- City of Hope Cancer Center (Data collection only), Duarte · 4 mi jauh
Effects of Dexrazoxane Hydrochloride on Biomarkers Associated With Cardiomyopathy and Heart Failure After Cancer Treatment
Mengambil pesertaKajian pemerhatian
- City of Hope Comprehensive Cancer Center, Duarte · 4 mi jauh
A Study of Olverembatinib in Patients With Newly Diagnosed Ph+ ALL (POLARIS-1)
Mengambil pesertaFasa 3
- Ascentage Investigative Site #1062, Duarte · 4 mi jauh
Orca-T Following Chemotherapy and Total Marrow and Lymphoid Irradiation for the Treatment of Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia or Myelodysplastic Syndrome
Mengambil pesertaFasa 1Sukarelawan sihat dialu-alukan
- City of Hope Medical Center, Duarte · 4 mi jauh
Allogeneic CMV-Specific CD19-CAR T Cells Plus CMV-MVA Triplex Vaccine After Matched Related Donor Hematopoietic Cell Transplant for the Treatment of Patients With High-Risk Acute Lymphoblastic Leukemia
Mengambil pesertaFasa awal 1
- City of Hope Medical Center, Duarte · 4 mi jauh
A Platform Protocol to Investigate Post-Transplant Cyclophosphamide-Based Graft-Versus-Host Disease Prophylaxis in Patients With Hematologic Malignancies Undergoing Mismatched Unrelated Donor Peripheral Blood Stem Cell Transplantation
Mengambil pesertaFasa 2
- City of Hope, Duarte · 4 mi jauh
Asparaginase Erwinia Chrysanthemi With Chemotherapy for the Treatment of High-Risk Adults With Newly Diagnosed Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma
Mengambil pesertaFasa 2
- City of Hope Medical Center, Duarte · 4 mi jauh
CMV-MVA Triplex Vaccination in HLA-Matched Related Stem Cell Donors for the Prevention of CMV Infection in Patients Undergoing Hematopoietic Stem Cell Transplant
Mengambil pesertaFasa 2Sukarelawan sihat dialu-alukan
- City of Hope Medical Center, Duarte · 4 mi jauh
Revumenib for the Treatment of Acute Leukemia in Patients Post-Allogeneic Stem Cell Transplant
Mengambil pesertaFasa 1
- City of Hope Medical Center, Duarte · 4 mi jauh
Exercise Training and NR Supplementation Trial to Improve Fitness in AYA HCT Survivors
Mengambil pesertaFasa 2
- City of Hope Medical Center, Duarte · 4 mi jauh
Study of HQP1351 in Subjects With Refractory CML and Ph+ ALL
Mengambil pesertaFasa 1
- City of Hope, Duarte · 4 mi jauh
Ruxolitinib With Tacrolimus and Methotrexate for the Prevention of Graft Versus Host Disease in Pediatric and Young Adult Patients Undergoing Allogeneic Hematopoietic Cell Transplant for Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, or Myelodysplastic Syndrome
Mengambil pesertaFasa 2
- City of Hope Medical Center, Duarte · 4 mi jauh
Prevention of GvHD in Participants With Hematological Malignancies Undergoing Hematopoietic Stem Cell Transplant (HSCT)
Mengambil pesertaFasa 1
- City of Hope, Duarte · 4 mi jauh
Kajian Leukemia Limfoblastik Akut di bandar lain
- Houston, TX28 kajian
- New York City, NY24 kajian
- Seattle, WA21 kajian
- Chicago, IL19 kajian
- Atlanta, GA19 kajian
- Philadelphia, PA16 kajian
- Memphis, TN16 kajian
- Washington, DC16 kajian
- Boston, MA15 kajian
- Los Angeles, CA14 kajian
- Durham, NC13 kajian
- Mountain View, CA13 kajian
Kajian lain di Baldwin Park
- Kanser Payudara45 kajian
- Leukemia Mieloid Akut40 kajian
- Kanser Kolorektal38 kajian
- Kanser Paru-paru Bukan Sel Kecil36 kajian
- Kanser (semua jenis)33 kajian
- Kanser Prostat30 kajian
- Kanser Metastatik30 kajian
- Sindrom Mielodisplastik26 kajian
- Kanser Ovari25 kajian
- Kanser Paru-paru24 kajian
- Mieloma Pelbagai23 kajian
- Kanser Perut22 kajian
Daripada ClinicalTrials.gov, data diperoleh pada 5 Okt 2026. Setiap kajian menetapkan kriteria kelayakannya sendiri; pasukan kajian menentukan siapa yang layak menyertai.